Skip to main content

Factor V Inhibitor and Anti-Phospholipid Antibodies after Treatment with Ciprofloxacin

  • Conference paper
32nd Hemophilia Symposium
  • 100 Accesses

Abstract

The development of factor V inhibitor is very rare, especially in combination with raised antiphospholipid (aPL) antibodies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995;74:1185–90.

    PubMed  CAS  Google Scholar 

  2. Scharrer I, Fürstenau C, Stotz D, MÜller-Beiβenhirtz W, Ehrenforth S, von Depka Prondzinski M, Siegert S: Auftreten eines Faktor V-Hemmkörpers und Auftreten von Lupus-Antikoagulanzien nach Ciprofloxacin. In: I.Scharrer/ W. Schramm: 25 Hämophilie-Symposium Hamburg 1994,388–92, Springer-Verlag Berlin Heidelberg 1996.

    Google Scholar 

  3. Castaman Rodeghiero F. (1994): Acquired transitory von Willebrand Syndrome with ciprofloxacin. Lancet 343:492

    Article  Google Scholar 

  4. Choe U., Rothschild B. M., Laitman L. (1989): Ciprofloxacin-induced vasculitis. N Engl J Med 320: 257–258

    PubMed  CAS  Google Scholar 

  5. Kanuga J., Holland C.L., Reyes R., Bielory L. (1991): Ciprofloxacin induced leukocytoplastic vasculitis with cryoglobulinemia. Ann Allergy 66–67

    Google Scholar 

  6. Stubbings J., Sheehan-Dare R., Walton S. (1992): Cutaneous vasculititis due to ciprofloxacin. Br Med J 305–29

    Google Scholar 

  7. van Beek E.J.R., Peters M., ten Cate J.W. (1993): Factor VIII inhibitor associated with ciprofloxacin. Thromb Haemostas 69(4):403

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Miesbach, W. et al. (2003). Factor V Inhibitor and Anti-Phospholipid Antibodies after Treatment with Ciprofloxacin. In: Scharrer, I., Schramm, W. (eds) 32nd Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18150-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18150-4_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-43884-7

  • Online ISBN: 978-3-642-18150-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics